Short answer
Intuitive Surgical (ISRG) filed its Q1 2026 10-Q quarterly report on Apr 22, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $2.8B (up 23.0% year over year) with net income of $822M.
Q1 2026 key financials · XBRL
- Revenue
- $2.8B
- +23.0% YoY
- Net income
- $822M
- +17.6% YoY
- Operating margin
- 30.9%
- Gross margin
- 66.1%
- EPS (diluted)
- $2.28
- +18.7% YoY
Source: XBRL data from the Intuitive Surgical (ISRG) Q1 2026 10-Q on SEC EDGAR. USD.
Intuitive Surgical Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- No actual profitability or margin percentages provided in supplied text
- Da Vinci 5 installed base 1,464 systems; SP installed base 410 systems
- Tariffs and trade measures added approximately $28 million to total cost of revenue
- Headwinds: hospital financial pressure, tariffs, semiconductor lead times, supply constraints, and elongated regulatory timelines
Risk Factors
- No risk-factors section provided; submitted text contains Items 2–6 instead
- Stock-repurchase liquidity use: $2.3 billion spent on 2,303,225 shares during the quarter
- Capital-allocation risk: Repurchase authorization remaining declined from $1.7 billion to $0.6 billion
- Insider-trading compliance exposure: CEO David J. Rosa adopted a Rule 10b5-1 plan covering up to 45,750 shares
- Executive equity-sale concentration: CFO Jamie E. Samath’s plan covers up to 23,171 shares through May 20, 2027
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Intuitive Surgical quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.